GPO Of Thailand To Quadruple Production Of Tamiflu Generic
This article was originally published in PharmAsia News
Executive Summary
Thailand's Government Pharmaceutical Organization has decided to increase production of its generic of Roche's Tamiflu (oseltamivir) antiviral to deal with a sharp increase in cases of H1N1 flu virus. GPO's director general said the firm expects to receive the API from India next week and begin production immediately. GPO, which also is working on an H1N1 vaccine, produces its Tamiflu generic under a controversial law that allows the government to circumvent patent protection on certain vital drugs when it deems such action necessary. The current 10 million-dose production level is to be increased to 40 million, GPO said. (Click here for more